4-phenylbutyric acid and chlorine

4-phenylbutyric acid has been researched along with chlorine in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (42.86)18.2507
2000's3 (42.86)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Egan, ME; Rubenstein, RC; Zeitlin, PL1
Rubenstein, RC; Zeitlin, PL1
Loffing, J; Moyer, BD; Reynolds, D; Stanton, BA1
Boyle, MP; Brass-Ernst, L; Diener-West, M; Lee, CK; Rubenstein, RC; Zeitlin, PL1
Andersson, C; Roomans, GM; Servetnyk, Z1
Floyd, AD; Kwon, E; Lim, M; McKenzie, K; Zeitlin, PL1
Deng, Y; Liu, C; Liu, W; Ma, Z; Tan, X; Wang, C; Xu, B; Xu, ZF; Yan, DY; Yang, TY1

Trials

2 trial(s) available for 4-phenylbutyric acid and chlorine

ArticleYear
A pilot clinical trial of oral sodium 4-phenylbutyrate (Buphenyl) in deltaF508-homozygous cystic fibrosis patients: partial restoration of nasal epithelial CFTR function.
    American journal of respiratory and critical care medicine, 1998, Volume: 157, Issue:2

    Topics: Administration, Oral; Adolescent; Adult; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Electrophysiology; Female; Homozygote; Humans; Male; Mutation; Nasal Cavity; Phenylbutyrates; Pilot Projects; Sweat

1998
Evidence of CFTR function in cystic fibrosis after systemic administration of 4-phenylbutyrate.
    Molecular therapy : the journal of the American Society of Gene Therapy, 2002, Volume: 6, Issue:1

    Topics: Adult; Biological Transport, Active; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Female; Humans; Male; Nasal Mucosa; Phenylbutyrates

2002

Other Studies

5 other study(ies) available for 4-phenylbutyric acid and chlorine

ArticleYear
In vitro pharmacologic restoration of CFTR-mediated chloride transport with sodium 4-phenylbutyrate in cystic fibrosis epithelial cells containing delta F508-CFTR.
    The Journal of clinical investigation, 1997, Nov-15, Volume: 100, Issue:10

    Topics: Biological Transport; Cells, Cultured; Chlorides; Colforsin; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; Immunohistochemistry; Kinetics; Membrane Potentials; Nasal Mucosa; Nasal Polyps; Patch-Clamp Techniques; Phenylbutyrates; Point Mutation

1997
PBA increases CFTR expression but at high doses inhibits Cl(-) secretion in Calu-3 airway epithelial cells.
    The American journal of physiology, 1999, Volume: 277, Issue:4

    Topics: Butyrates; Cell Line; Chlorides; Cystic Fibrosis Transmembrane Conductance Regulator; Dose-Response Relationship, Drug; Electric Conductivity; Epithelial Cells; Humans; Phenylbutyrates; Respiratory System; Sodium-Potassium-Exchanging ATPase; Valproic Acid

1999
Activation of CFTR by genistein in human airway epithelial cell lines.
    Biochemical and biophysical research communications, 2003, Aug-29, Volume: 308, Issue:3

    Topics: Cell Line; Chlorides; Cystic Fibrosis Transmembrane Conductance Regulator; Dose-Response Relationship, Drug; Epithelial Cells; Genistein; Humans; Ion Transport; Phenylbutyrates; Respiratory Mucosa

2003
Modulation of deltaF508 cystic fibrosis transmembrane regulator trafficking and function with 4-phenylbutyrate and flavonoids.
    American journal of respiratory cell and molecular biology, 2004, Volume: 31, Issue:3

    Topics: Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Dose-Response Relationship, Drug; Drug Therapy, Combination; Flavonoids; Humans; Molecular Chaperones; Phenylbutyrates; Protein Folding; Protein Transport; Respiratory Mucosa; Up-Regulation

2004
Effect of the cross-talk between autophagy and endoplasmic reticulum stress on Mn-induced alpha-synuclein oligomerization.
    Environmental toxicology, 2018, Volume: 33, Issue:3

    Topics: Adenine; alpha-Synuclein; Animals; Apoptosis; Autophagy; Brain; Butylamines; Chlorides; Endoplasmic Reticulum Stress; Environmental Pollutants; Manganese; Manganese Compounds; Mice, Inbred C57BL; Neurons; Phenylbutyrates; Polymerization; Signal Transduction; Sirolimus

2018